ArticleCancers2024

Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine.

Marie Buchholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.